|
1
|
Goodenberger ML and Jenkins RB: Genetics
of adult glioma. Cancer Genet. 205:613–621. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bleeker FE, Molenaar RJ and Leenstra S:
Recent advances in the molecular understanding of glioblastoma. J
Neurooncol. 108:11–27. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Weis WI and Nelson WJ: Re-solving the
cadherin-catenin-actin conundrum. J Biol Chem. 281:35593–35597.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Saldanha G, Ghura V, Potter L and Fletcher
A: Nuclear beta-catenin in basal cell carcinoma correlates with
increased proliferation. Br J Dermatol. 151:157–164. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
MacDonald BT, Tamai K and He X:
Wnt/beta-catenin signaling: Components, mechanisms, and diseases.
Dev Cell. 17:9–26. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Tao H, Guo L, Chen L, Qiao G, Meng X, Xu B
and Ye W: MSX1 inhibits cell migration and invasion through
regulating the Wnt/β-catenin pathway in glioblastoma. Tumour Biol.
37:1097–1104. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Singh T and Katiyar SK: Green tea
polyphenol, (−)-epigallocatechin-3-gallate, induces toxicity in
human skin cancer cells by targeting β-catenin signaling. Toxicol
Appl Pharmacol. 273:418–424. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Dong HJ, Jang GB, Lee HY, Park SR, Kim JY,
Nam JS and Hong IS: The Wnt/β-catenin signaling/Id2 cascade
mediates the effects of hypoxia on the hierarchy of
colorectal-cancer stem cells. Sci Rep. 6:229662016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wei A, Fan B, Zhao Y, Zhang H, Wang L, Yu
X, Yuan Q, Yang D and Wang S: ST6Gal-I overexpression facilitates
prostate cancer progression via the PI3K/Akt/GSK-3β/β-catenin
signaling pathway. Oncotarget. 7:65374–65388. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chen J, Rajasekaran M, Xia H, Zhang X,
Kong SN, Sekar K, Seshachalam VP, Deivasigamani A, Goh BK, Ooi LL,
et al: The microtubule-associated protein PRC1 promotes early
recurrence of hepatocellular carcinoma in association with the
Wnt/β-catenin signalling pathway. Gut. 65:1522–1534. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lal A, Kim HH, Abdelmohsen K, Kuwano Y,
Pullmann R Jr, Srikantan S, Subrahmanyam R, Martindale JL, Yang X,
Ahmed F, et al: p16(INK4a) translation suppressed by miR-24. PLoS
One. 3:e18642008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lal A, Navarro F, Maher CA, Maliszewski
LE, Yan N, O'Day E, Chowdhury D, Dykxhoorn DM, Tsai P, Hofmann O,
et al: miR-24 inhibits cell proliferation by targeting E2F2, MYC,
and other cell-cycle genes via binding to ‘seedless’ 3′UTR microRNA
recognition elements. Mol Cell. 35:610–625. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Amelio I, Lena AM, Viticchiè G,
Shalom-Feuerstein R, Terrinoni A, Dinsdale D, Russo G, Fortunato C,
Bonanno E, Spagnoli LG, et al: miR-24 triggers epidermal
differentiation by controlling actin adhesion and cell migration. J
Cell Biol. 199:347–363. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang Q, Huang Z, Xue H, Jin C, Ju XL, Han
JD and Chen YG: MicroRNA miR-24 inhibits erythropoiesis by
targeting activin type I receptor ALK4. Blood. 111:588–595. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yin Y, Zhong J, Li SW, Li JZ, Zhou M, Chen
Y, Sang Y and Liu L: TRIM11, a direct target of miR-24-3p, promotes
cell proliferation and inhibits apoptosis in colon cancer.
Oncotarget. 7:86755–86765. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Pan B, Chen Y, Song H, Xu Y, Wang R and
Chen L: Mir-24-3p downregulation contributes to VP16-DDP resistance
in small-cell lung cancer by targeting ATG4A. Oncotarget.
6:317–331. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cherra SJ III, Kulich SM, Uechi G,
Balasubramani M, Mountzouris J, Day BW and Chu CT: Regulation of
the autophagy protein LC3 by phosphorylation. J Cell Biol.
190:533–539. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Huang SM, Mishina YM, Liu S, Cheung A,
Stegmeier F, Michaud GA, Charlat O, Wiellette E, Zhang Y, Wiessner
S, et al: Tankyrase inhibition stabilizes axin and antagonizes Wnt
signalling. Nature. 461:614–620. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Cui Y, Ma W, Lei F, Li Q, Su Y, Lin X, Lin
C, Zhang X, Ye L, Wu S, et al: Prostate tumour overexpressed-1
promotes tumourigenicity in human breast cancer via activation of
Wnt/β-catenin signalling. J Pathol. 239:297–308. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wu S, Wang S, Zheng S, Verhaak R, Koul D
and Yung WK: MSK1-mediated β-catenin phosphorylation confers
resistance to PI3K/mTOR inhibitors in glioblastoma. Mol Cancer
Ther. 15:1656–1668. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yan Z, Wang J, Wang C, Jiao Y, Qi W and
Che S: miR-96/HBP1/Wnt/β-catenin regulatory circuitry promotes
glioma growth. FEBS Lett. 588:3038–3046. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Guo M, Zhang X, Wang G, Sun J, Jiang Z,
Khadarian K, Yu S, Zhao Y, Xie C, Zhang K, et al: miR-603 promotes
glioma cell growth via Wnt/β-catenin pathway by inhibiting WIF1 and
CTNNBIP1. Cancer Lett. 360:76–86. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Liu Y, Cui M, Lu Z, Yang Q and Dong Q:
Tissue kallikrein promotes survival and β-catenin degradation in
SH-SY5Y cells under nutrient stress conditions via autophagy. Mol
Med Rep. 13:1389–1394. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Tian R, Li Y and Yao X: PGRN suppresses
inflammation and promotes autophagy in keratinocytes through the
Wnt/β-catenin signaling pathway. Inflammation. 39:1387–1394. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
McCord M, Mukouyama YS, Gilbert MR and
Jackson S: Targeting WNT signaling for multifaceted glioblastoma
therapy. Front Cell Neurosci. 11:3182017. View Article : Google Scholar : PubMed/NCBI
|
